Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.
Crohn’s disease
Faecal incontinence
Fatigue
Inflammatory bowel disease
Online self-management
Pain
RCT
Ulcerative colitis
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
03 Aug 2021
03 Aug 2021
Historique:
received:
14
11
2020
accepted:
16
07
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
6
8
2021
Statut:
epublish
Résumé
Despite being in clinical remission, many people with inflammatory bowel disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support. In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0-10 scale) compared with care as usual? A pragmatic two-arm, parallel group randomised controlled trial (RCT), of a 12-session facilitator-supported online cognitive behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation. We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups. The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients' quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals. ISRCTN71618461 . Registered on 9 September 2019.
Sections du résumé
BACKGROUND
BACKGROUND
Despite being in clinical remission, many people with inflammatory bowel disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness of an online self-management programme (BOOST), developed using cognitive behavioural principles and a theoretically informed logic model, and delivered with facilitator support.
PRIMARY RESEARCH QUESTION
UNASSIGNED
In people with IBD who report symptoms of fatigue, pain or urgency and express a desire for intervention, does a facilitator-supported tailored (to patient needs) online self-management programme for fatigue, pain and faecal urgency/incontinence improve IBD-related quality of life (measured using the UK-IBDQ) and global rating of symptom relief (0-10 scale) compared with care as usual?
METHODS
METHODS
A pragmatic two-arm, parallel group randomised controlled trial (RCT), of a 12-session facilitator-supported online cognitive behavioural self-management programme versus care as usual to manage symptoms of fatigue, pain and faecal urgency/incontinence in IBD. Patients will be recruited through a previous large-scale survey of unselected people with inflammatory bowel disease. The UK Inflammatory Bowel Disease Questionnaire and global rating of symptom relief at 6 months are the co-primary outcomes, with multiple secondary outcomes measured also at 6 and 12 months post randomisation to assess maintenance. The RCT has an embedded pilot study, health economics evaluation and process evaluation. We will randomise 680 patients, 340 in each group. Demographic characteristics and outcome measures will be presented for both study groups at baseline. The UK-IBDQ and global rating of symptom relief at 6 and 12 months post randomisation will be compared between the study groups.
DISCUSSION
CONCLUSIONS
The BOOST online self-management programme for people with IBD-related symptoms of fatigue, pain and urgency has been designed to be easily scalable and implemented. If it is shown to improve patients' quality of life, this trial will enable clinicians and patients to make informed management decisions. This is the first trial, to our knowledge, focused on multiple symptoms prioritised by both people with IBD and health professionals.
TRIAL REGISTRATION
BACKGROUND
ISRCTN71618461 . Registered on 9 September 2019.
Identifiants
pubmed: 34344432
doi: 10.1186/s13063-021-05466-4
pii: 10.1186/s13063-021-05466-4
pmc: PMC8329619
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
516Subventions
Organisme : National Institute for Health Research
ID : RP-PG-0216-20001
Informations de copyright
© 2021. The Author(s).
Références
Gut. 1999 Jan;44(1):77-80
pubmed: 9862829
Gut. 2010 Dec;59(12):1652-61
pubmed: 21071584
Eur J Gastroenterol Hepatol. 2014 Aug;26(8):910-7
pubmed: 24942954
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Gastroenterology. 2018 Jul;155(1):47-57
pubmed: 29702118
J Crohns Colitis. 2013 Sep;7(8):e302-11
pubmed: 23228710
J Clin Epidemiol. 2000 Mar 1;53(3):297-306
pubmed: 10760641
J Psychosom Res. 2013 Aug;75(2):103-12
pubmed: 23915765
J Psychosom Res. 2015 Jan;78(1):12-24
pubmed: 25438982
Health Technol Assess. 2016 Jun;20(44):1-320
pubmed: 27329657
Aliment Pharmacol Ther. 2004 Jul 1;20(1):89-97
pubmed: 15225175
J Psychosom Res. 2013 Aug;75(2):113-20
pubmed: 23915766
BMC Gastroenterol. 2013 Apr 21;13:68
pubmed: 23602047
J Crohns Colitis. 2016 Jul;10(7):860-9
pubmed: 26802088
Patient Educ Couns. 2002 Jul;47(3):257-63
pubmed: 12088604
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Aliment Pharmacol Ther. 2015 Jul;42(2):203-11
pubmed: 25989464
Am J Psychiatry. 1997 Mar;154(3):408-14
pubmed: 9054791
Behav Res Ther. 2012 Jun;50(6):415-21
pubmed: 22516321
Inflamm Bowel Dis. 2013 Sep;19(10):2111-7
pubmed: 23883959
J Crohns Colitis. 2014 Aug;8(8):835-44
pubmed: 24491516
Eur J Gastroenterol Hepatol. 2020 Mar;32(3):335-344
pubmed: 31851083
Res Involv Engagem. 2016 Aug 20;2:29
pubmed: 29507764
Behav Res Ther. 2021 Feb;137:103464
pubmed: 31780252
BMJ. 2002 May 18;324(7347):1183
pubmed: 12016181
Psychol Med. 2010 Jan;40(1):85-94
pubmed: 19531276
Inflamm Bowel Dis. 2013 Jun;19(7):1450-62
pubmed: 23624884
Trials. 2017 May 11;18(1):213
pubmed: 28490349
J Wound Ostomy Continence Nurs. 2001 May;28(3):156-68
pubmed: 11337702
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Med Care. 1999 Jan;37(1):5-14
pubmed: 10413387
Trials. 2015 Oct 06;16:444
pubmed: 26445224
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
J Crohns Colitis. 2014 Nov;8(11):1398-406
pubmed: 24856864
J Psychosom Res. 2006 Nov;61(5):583-5
pubmed: 17084134
Cochrane Database Syst Rev. 2014 Feb 26;(2):CD010152
pubmed: 24574082
Gastroenterology. 2003 Nov;125(5):1320-9
pubmed: 14598248
Aliment Pharmacol Ther. 2017 Jul;46(2):115-125
pubmed: 28470846
Lancet Gastroenterol Hepatol. 2019 Nov;4(11):863-872
pubmed: 31492643
J Wound Ostomy Continence Nurs. 2004 Mar-Apr;31(2):85-94
pubmed: 15209431
Implement Sci. 2008 Oct 13;3:44
pubmed: 18851743
Arthritis Care Res. 1993 Dec;6(4):213-22
pubmed: 7918717
Inflamm Bowel Dis. 2016 Jan;22(1):171-81
pubmed: 26360545
Psychosom Med. 2008 Feb;70(2):205-13
pubmed: 18256342
Eff Clin Pract. 2001 Nov-Dec;4(6):256-62
pubmed: 11769298
Dis Colon Rectum. 2008 Apr;51(4):436-42
pubmed: 18219532
Health Psychol. 2007 Jul;26(4):464-72
pubmed: 17605566
Gut. 2014 Jul;63(7):1092-102
pubmed: 24107590
Gut. 2019 Sep;68(9):1613-1623
pubmed: 30971419
J Consult Clin Psychol. 2013 Apr;81(2):251-62
pubmed: 22730954
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Res Involv Engagem. 2015 Aug 7;1:8
pubmed: 29062497
Eur J Neurol. 2015 Nov;22(11):1443-52
pubmed: 26177836
J Adv Nurs. 2013 Sep;69(9):1987-99
pubmed: 23215959
Gut. 2004 Nov;53(11):1639-45
pubmed: 15479685
Cochrane Database Syst Rev. 2015 Mar 23;(3):CD011118
pubmed: 25803793